Workshop on G protein-coupled receptors and drug discovery 4th of May at AstraZeneca
GPCRs are one of the key targets for therapeutic approaches across many disease areas. However, only around 25% of the druggable GPCRs have been tapped into.
This presents a significant opportunity to develop novel medicines with high therapeutic impact for the GPCR class in numerous indications.
The Challenges in GPCR drug discovery workshop is co-organized by AstraZeneca, Gothenburg University, Uppsala University, InSingulo and AstraZeneca to explore the latest advancements in GPCR drug
discovery research. Our aim is to bring together renowned international experts from industry, academia and service providers to facilitate communication between scientific groups and research
areas within GPCR drug discovery community. We believe this will eventually lead to uncovering common challenges and finding new innovative approaches to drug discovery for GPCRs.
For registration and further information, please go to insingulo.com/registration
